We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $875B
1-Year Est. Return 40.91%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-13.42%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$390B
AUM Growth
-$94.7B
Cap. Flow
+$10.4B
Cap. Flow %
2.66%
Top 10 Hldgs %
28.21%
Holding
14,957
New
1,520
Increased
5,503
Reduced
5,522
Closed
2,191

Sector Composition

Rank Sector Weight
1 Healthcare 2.83%
2 Technology 2.79%
3 Financials 2.29%
4 Consumer Discretionary 1.93%
5 Industrials 1.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IRNT
9926
PUT
DELISTED
IronNet, Inc.
IRNT
$272K ﹤0.01%
123,100
-95,900
-44% -$271K
TPGY
9927
PUT
DELISTED
TPG Pace Beneficial Finance Corp.
TPGY
$272K ﹤0.01%
27,400
-42,100
-61% -$417K
AEHR icon
9928
PUT
Aehr Test Systems
AEHR
$4.37B
$271K ﹤0.01%
36,100
-40,500
-53% -$336K
APRE icon
9929
CALL
Aprea Therapeutics
APRE
$8.42M
$271K ﹤0.01%
18,295
-65
-0.4% -$1.5K
AQB icon
9930
PUT
AquaBounty Technologies
AQB
$7.67M
$271K ﹤0.01%
7,925
+3,515
+80% +$107K
CNNE icon
9931
CALL
Cannae Holdings
CNNE
$635M
$271K ﹤0.01%
+14,000
New +$294K
GIB icon
9932
PUT
CGI
GIB
$15.2B
$271K ﹤0.01%
3,400
-2,000
-37% -$161K
HAYW icon
9933
PUT
Hayward Holdings
HAYW
$3.22B
$271K ﹤0.01%
18,800
-44,500
-70% -$686K
LECO icon
9934
PUT
Lincoln Electric
LECO
$15.6B
$271K ﹤0.01%
2,200
-1,700
-44% -$224K
MTLS
9935
PUT
Materialise
MTLS
$400M
$271K ﹤0.01%
19,900
-33,600
-63% -$530K
UGL icon
9936
PUT
ProShares Ultra Gold
UGL
$801M
$271K ﹤0.01%
19,200
-6,800
-26% -$104K
UROY
9937
PUT
Uranium Royalty Corp
UROY
$1.57B
$271K ﹤0.01%
119,200
-16,400
-12% -$52.6K
BAL
9938
CALL
DELISTED
iPath Series B Bloomberg Cotton Subindex Total ReturnSM ETN
BAL
$271K ﹤0.01%
4,000
+500
+14% +$40.8K
HTPA
9939
DELISTED
Highland Transcend Partners I Corp.
HTPA
$271K ﹤0.01%
27,434
-975,673
-97% -$9.62M
TPTX
9940
PUT
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$271K ﹤0.01%
+3,600
New +$160K
AMTX icon
9941
CALL
Aemetis
AMTX
$128M
$270K ﹤0.01%
55,000
-31,600
-36% -$276K
FAF icon
9942
PUT
First American
FAF
$7.54B
$270K ﹤0.01%
5,100
-6,900
-58% -$402K
ILF icon
9943
CALL
iShares Latin America 40 ETF
ILF
$3.71B
$270K ﹤0.01%
+12,000
New +$320K
NTGR icon
9944
NETGEAR
NTGR
$656M
$270K ﹤0.01%
14,573
-24,030
-62% -$491K
SCHM icon
9945
CALL
Schwab US Mid-Cap ETF
SCHM
$15.4B
$270K ﹤0.01%
12,900
-1,500
-10% -$34.6K
YPF icon
9946
CALL
YPF Sociedad Anonima ADS
YPF
$19.6B
$270K ﹤0.01%
82,700
-38,700
-32% -$167K
SEV
9947
PUT
DELISTED
Sono Group N.V. Common Shares
SEV
$270K ﹤0.01%
92,000
+73,700
+403% +$286K
ARW icon
9948
PUT
Arrow Electronics
ARW
$10.9B
$269K ﹤0.01%
2,400
-1,000
-29% -$117K
FTDS icon
9949
First Trust Dividend Strength ETF
FTDS
$39.9M
$269K ﹤0.01%
6,599
-35,318
-84% -$1.58M
HEDJ icon
9950
CALL
WisdomTree Europe Hedged Equity Fund
HEDJ
$1.88B
$269K ﹤0.01%
+8,200
New +$294K

Similar funds

Citadel Advisors's Q2 2022 Portfolio in Review

As of Q2 2022, Citadel Advisors held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Citadel Advisors's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.

By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.

  • Citadel Advisors's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
  • Citadel Advisors added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
  • Citadel Advisors's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
  • Citadel Advisors fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
  • Citadel Advisors's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
  • Citadel Advisors opened 1,520 new positions and closed 2,191 in Q2 2022.
  • Citadel Advisors's portfolio value fell 20% quarter-over-quarter to $390B.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.